The bill inserts a new statutory provision into Title V of the Public Health Service Act creating a federal grant program for eligible entities to support administration of emergency opioid-overdose drugs and devices in elementary and secondary schools. It also amends existing grant language to permit funding of administering as well as prescribing and updates appropriation text to cover the new program.
This is a focused, programmatic intervention: federal dollars flow to jurisdictions that certify schools will staff trained personnel, keep an accessible supply, and that state law provides liability protection. The measure directly raises operational, training, and legal-certification tasks for state education agencies and school districts while placing the Department of Health and Human Services in the role of awarding and overseeing grants.
At a Glance
What It Does
Creates Section 544A in the Public Health Service Act authorizing the Secretary to award grants to eligible entities so that trained personnel in K–12 schools can use drugs and devices for emergency treatment of known or suspected opioid overdoses. It amends Section 544(c) to include 'administering' alongside 'prescribing' and updates the appropriation authority to cover the new section.
Who It Affects
State and local education agencies, public and private K–12 schools, school nurses and school-based health center staff, and state attorneys general who must certify applicable civil-liability protections. HHS will gain new grant administration responsibilities.
Why It Matters
The measure removes a funding barrier to placing reversal drugs and trained staff in schools and creates a federal lever to expand access to lifesaving treatment where children and staff spend much of their day. It also forces jurisdictions to confront gaps in legal protections, training standards, and on-site staffing logistics.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill makes three legal changes. First, it tweaks existing grant language (Section 544 of the Public Health Service Act) to make clear federal grant funds may support not only prescribing but administering overdose treatments.
Second, it amends appropriation language so money appropriated for Section 544 can also be used for a newly created program. Third, it inserts a new Section 544A that authorizes a discrete grant program targeted at elementary and secondary schools.
Under the new Section 544A, the Secretary of Health and Human Services may award grants to 'eligible entities' (the term points back to Section 544’s definitional framework) to provide for the administration, at schools under that entity’s jurisdiction, of drugs and devices for emergency treatment of known or suspected opioid overdose. Applicants must submit an application that meets the procedural requirements already established in Section 544(b) and additional information the Secretary requests.Critically, applicants must provide certifications covering each school in their jurisdiction: the school will permit trained personnel to administer the treatments; the school will keep a supply of drugs/devices in a location that trained staff can access easily; the school will have a plan to have one or more trained individuals on premises during all operating hours.
The statute requires the State attorney general to review and certify that state civil-liability protection law applies to those trained school personnel and provides 'adequate' protection—language that conditions funding on a legal determination at the state level.The statute defines key terms: 'civil liability protection law' (a state law protecting individuals who give emergency aid), 'trained personnel' (school nurse, trained school-based health center staff, or an individual otherwise designated by school leadership), and sets minimum documentation and training expectations—training must meet appropriate medical standards and be documented by school administrative staff. The bill applies to both public and private elementary and secondary schools within an eligible entity’s jurisdiction and leaves the Secretary discretion to require additional application material or documentation as part of the grant award process.
The Five Things You Need to Know
The bill creates a new Section 544A that explicitly authorizes grants to support administration (not just prescribing) of emergency opioid-overdose drugs and devices at K–12 schools, including private schools under an eligible entity’s jurisdiction.
Grant applicants must certify, for each school, three operational commitments: permission for trained personnel to administer the drug/device, an easily accessible on-site supply, and a plan to have one or more trained individuals present during all school operating hours.
The State attorney general must certify that existing state 'civil liability protection' laws apply to and adequately protect school personnel who administer emergency aid—making funding contingent on a legal finding by the State AG.
The bill defines 'trained personnel' to include school nurses, trained school-based health center staff, or other individuals designated by school leadership, and requires documented training that meets 'appropriate medical standards.', It amends Section 544(c) of the Public Health Service Act to add 'administering' after 'prescribing' and revises the appropriation clause in 544(g) so funds can be used to carry out the new 544A program.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
Declares the Act would be cited as the 'School Access to Naloxone Act of 2026.' Practical implication: any regulations, guidance, or references to the program will use this statutory short title.
Permit 'Administering' and Expand Appropriation Scope
Changes Section 544(c) to insert 'administering' alongside 'prescribing,' clarifying that grant activities may fund hands-on administration of overdose treatments rather than only prescription-related activities. It also amends the appropriation text in Section 544(g) so that appropriated funds explicitly may be used to carry out both Section 544 and the new Section 544A—removing an explicit funding gap between the older program and the school-focused program.
Grant Authority Targeted to Schools
Authorizes HHS to award grants to eligible entities to 'provide for the administration' at elementary and secondary schools of drugs and devices for emergency opioid treatment. The statutory language places the Secretary in charge of award decisions and establishes the program's focus on in-school, immediate-response capacity.
Application Requirements
Requires applicants to follow the application process set out in Section 544(b) and to furnish additional certifications and any other information the Secretary requires. Practically, jurisdictions that already apply under Section 544 will have an existing procedural template, but HHS retains discretion to add tailored reporting or documentation specific to schools.
Per-School Certifications and AG Review
Lists four per-school certifications applicants must make, including operational commitments on training and supplies and a plan for staffing during operating hours. It also requires the State attorney general to review and certify that applicable state civil-liability protection laws apply and are 'adequate'—a legal gating item that ties federal grant eligibility to state-level liability frameworks.
Key Definitions
Defines 'civil liability protection law,' 'eligible entity' (by cross-reference to Section 544), and 'trained personnel.' The 'trained personnel' definition specifies who may administer treatment, requires documented training that meets 'appropriate medical standards,' and delegates designation authority to school principals or appropriate administrators.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Students and school staff in areas with opioid exposure — they gain on-site, potentially life-saving emergency treatment when an overdose occurs during school hours.
- School nurses and school-based health centers — the program funds training and supplies, and statutorily recognizes their role in emergency overdose response.
- Local education agencies and eligible entities — federal grants can offset costs of training, stocking, and protocol development that districts otherwise would fund locally.
- State public health agencies and HHS grantees — the program creates a federal funding stream to coordinate school-based overdose-prevention activities and formalize protocols.
Who Bears the Cost
- State attorneys general and state legal offices — must review laws and provide formal certifications about civil-liability protections, consuming legal staff time and potentially prompting legislative fixes in jurisdictions with gaps.
- School districts and private schools — even with grant funds, schools will shoulder operational work: training, maintaining accessible supplies, scheduling to ensure trained staff are on-site, and recordkeeping.
- HHS and grant administrators — Federal staff will need to design application review criteria, monitor compliance across many schools, and enforce documentation and training standards.
- Liability insurers and school legal counsel — may see increased demand to reassess coverage and advise on implementation; insurers might raise rates or impose new coverage conditions for participating schools.
Key Issues
The Core Tension
The bill balances two legitimate goals—rapidly expanding access to lifesaving overdose reversal in schools versus placing operational, legal, and financial responsibility on state and local actors without clear, uniform standards. Expanding immediate treatment capacity can save lives, but making grants contingent on state AG certifications and vague training standards shifts complexity to jurisdictions and risks uneven rollout across states.
The statute ties federal grant eligibility to a State AG’s affirmative conclusion that existing civil-liability protection law is 'adequate.' That creates two implementation risks: first, states whose laws fall short may need loopback legislation or AG opinions before jurisdictions can receive federal funds; second, 'adequate' is undefined, inviting inconsistent interpretations across states and potential litigation over certification sufficiency. The AG gate also shifts political and legal pressure from school districts to state legal offices.
Operationally, the bill requires schools to keep an 'easily accessible' supply and to have a plan to have trained personnel on-site during all operating hours. Neither 'easily accessible' nor minimum training standards are quantified; 'appropriate medical standards' is the statutory benchmark but the Secretary retains discretion to specify details.
Those gaps create implementation burdens: districts must decide what documentation satisfies HHS, allocate staff time (and possibly hire additional staff) to meet the 'on premises' staffing plan, and create inventory and expiration-tracking systems for drugs and devices. Finally, by focusing on emergency response, the program does not address upstream prevention or treatment pathways; districts may face community expectations to pair naloxone availability with broader student- and staff-facing substance-use strategies despite no funding earmarked for them in the text.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.